Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar-Apr;61(2):134-142.
doi: 10.1016/j.rx.2018.10.009. Epub 2018 Dec 21.

Immunotherapy in oncology: a new challenge for radiologists

[Article in English, Spanish]
Affiliations

Immunotherapy in oncology: a new challenge for radiologists

[Article in English, Spanish]
A Bustos Fiore et al. Radiologia (Engl Ed). 2019 Mar-Apr.

Abstract

Objective: In patients with oncologic disease, immunotherapy has become established as an alternative or complementary therapy to traditional treatment options (surgery, radiotherapy, and chemotherapy). Currently available immunotherapy modes can be divided into two types: passive and active. The active type strengthens the immune system's response to tumor cells by activating both humoral immunity and cell-mediated immunity, using the adaptive response. This article aims to analyze the radiologic patterns of the response to immunotherapy through immune-response-related criteria and to describe the main adverse effects associated with this treatment approach.

Conclusion: Imaging tests play a fundamental role in the follow-up of oncologic patients and in the assessment of their response to treatment. Immunotherapy represents a challenge for radiologists both in the evaluation of the response to immunotherapy and in the detection of the adverse effects associated with this treatment approach.

Keywords: Adverse events; Criteria for immune response; Criterios de respuesta inmunológica; Directed molecular therapy; Eventos adversos; Imagen en oncología; Imaging in oncology; Immunotherapy; Inmunoterapia; Terapia molecular dirigida.

PubMed Disclaimer

MeSH terms

LinkOut - more resources